Clinical Trials Directory

Trials / Completed

CompletedNCT05080868

Infantile Hemangioma With Minimal or Arrested Growth : Epidemiology, Clinical Characteristics and Evolution

Comparing Epidemiological and Clinical Characteristics of Infantile Hemangioma With Minimal or Arrested Growth (IH-MAG) and Classic Infantile Hemangioma : a Retrospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
224 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
1 Day – 18 Years
Healthy volunteers
Accepted

Summary

Infantile hemangioma (IH) is the most common vascular tumor of infancy, characterized by its clinical history. Absent at birth or present under the form of a premonitory mark, they display a rapid proliferative phase starting in the first weeks of life. Then, after a plateau phase, they slowly involute. However, a subtype of IH named "abortive", "minimal or arrested growth", "reticular" or "telangiectatic" hemangioma differs from typical IH because it doesn't have a proliferative component, or only a minimal one. This subtype of hemangioma has been recently described and data are lacking regarding its proportion among infantile hemangioma and its differences with "classic" infantile hemangioma. The aim of this study is to estimate the proportion of abortive hemangioma among infantile hemangioma. Also, the investigators aim to compare the clinical characteristics of "classic" infantile hemangiomas and abortive hemangiomas. Lastly, investigators wished to study the evolution of abortive hemangioma.

Conditions

Timeline

Start date
2021-03-23
Primary completion
2021-05-30
Completion
2021-08-15
First posted
2021-10-18
Last updated
2021-10-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05080868. Inclusion in this directory is not an endorsement.